ArticlePDF Available

Effect of Honey on Nocturnal Cough and Sleep Quality: A Double-blind, Randomized, Placebo-Controlled Study

American Academy of Pediatrics
Pediatrics
Authors:

Abstract and Figures

To compare the effects of a single nocturnal dose of 3 honey products (eucalyptus honey, citrus honey, or labiatae honey) to placebo (silan date extract) on nocturnal cough and difficulty sleeping associated with childhood upper respiratory tract infections (URIs). A survey was administered to parents on 2 consecutive days, first on the day of presentation, when no medication had been given the previous evening, and the following day, when the study preparation was given before bedtime, based on a double-blind randomization plan. Participants included 300 children aged 1 to 5 years with URIs, nocturnal cough, and illness duration of ≤ 7 days from 6 general pediatric community clinics. Eligible children received a single dose of 10 g of eucalyptus honey, citrus honey, labiatae honey, or placebo administered 30 minutes before bedtime. Main outcome measures were cough frequency, cough severity, bothersome nature of cough, and child and parent sleep quality. In all 3 honey products and the placebo group, there was a significant improvement from the night before treatment to the night of treatment. However, the improvement was greater in the honey groups for all the Parents rated the honey products higher than the silan date extract for symptomatic relief of their children's nocturnal cough and sleep difficulty due to URI. Honey may be a preferable treatment for cough and sleep difficulty associated with childhood URI.
Content may be subject to copyright.
Effect of Honey on Nocturnal Cough and Sleep Quality:
A Double-blind, Randomized, Placebo-Controlled Study
WHATS KNOWN ON THIS SUBJECT: Honey is recommended as
a cough medication by the World Health Organization. To date, the
efcacy of this treatment has been shown in 2 studies: one tested
only buckwheat honey and the other study was not blinded.
WHAT THIS STUDY ADDS: In a randomized controlled trial, we
compared 3 types of honey versus placebo as a treatment of
upper respiratory tract infectionassociated cough. These types
of honey were superior to placebo in alleviating cough.
abstract
OBJECTIVES: To compare the effects of a single nocturnal dose of 3
honey products (eucalyptus honey, citrus honey, or labiatae honey) to
placebo (silan date extract) on nocturnal cough and difculty sleeping
associated with childhood upper respiratory tract infections (URIs).
METHODS: A survey was administered to parents on 2 consecutive
days, rst on the day of presentation, when no medication had been
given the previous evening, and the following day, when the study prep-
aration was given before bedtime, based on a double-blind randomization
plan. Participants included 300 children aged 1 to 5 years with URIs,
nocturnal cough, and illness duration of #7daysfrom6general
pediatric community clinics. Eligible children received a single dose of
10 g of eucalyptus honey, citrus honey, labiatae honey, or placebo
administered 30 minutes before bedtime. Main outcome measures
were cough frequency, cough severity, bothersome nature of cough,
and child and parent sleep quality.
RESULTS: In all 3 honey products and the placebo group, there was
a signicant improvement from the night before treatment to the night
of treatment. However, the improvement was greater in the honey
groups for all the main outcome measures.
CONCLUSIONS: Parents rated the honey products higher than the silan
date extract for symptomatic relief of their childrens nocturnal cough
and sleep difculty due to URI. Honey may be a preferable treatment
for cough and sleep difculty associated with childhood URI. Pediatrics
2012;130:465471
AUTHORS: Herman Avner Cohen, MD,
a
,
b
Josef Rozen, MD,
b
,
c
,
Haim Kristal, MD,
b
,
d
Yoseph Laks, MD,
b
,
e
Mati Berkovitch,
MD,
b
,
f
Yos e f Uzi el, MD ,
b
,
g
Eran Kozer, MD,
b
,
h
Avishalom
Pomeranz, MD,
b
,
i
and Haim Efrat
j
a
Pediatric Ambulatory Community Clinic, Petach Tikva, Israel;
b
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel;
c
Pediatric Ambulatory Community Clinic, Kefar Saba, Israel;
d
Pediatric Ambulatory Community Clinic, Kiryat Shmone, Israel;
e
Pediatric Ambulatory Community Clinic, Ramat Aviv, Israel;
f
Clinical Pharmacology Unit, Assaf Harofeh Medical Center,
Zerin, Israel;
g
Department of Pediatrics, Meir Medical Center,
Kfar Saba, Israel;
h
Pediatric Emergency Unit, Assaf Harofeh
Medical Center, Zerin, Israel;
i
Department of Pediatrics, Meir
Medical Center, Kfar Saba, Israel; and
j
Zerin Breeding Apiary,
Volcani Agricultural Research Center, Rechovot, Israel
KEY WORDS
cough, children, honey
ABBREVIATIONS
FDAFood and Drug Administration
OTCover-the-counter
URIupper respiratory tract infection
Deceased.
Dr Cohen was responsible for conception and design of study,
data acquisition, analysis and interpretation of data, and he
drafted and revised the article and approved the nal version;
Dr Rozen was responsible for data acquisition, data analysis and
interpretation, and critical revision of the article; Drs Kristal,
Laks, Berkovitch, Uziel, Kozer, and Pomeranz were responsible
for data acquisition, data analysis and interpretation, revising
the article, and approving the nal version; and Mr Haim was
responsible for preparing blinded specimens.
This trial has been registered at www.clinicaltrials.gov
(identier NCT01575821).
www.pediatrics.org/cgi/doi/10.1542/peds.2011-3075
doi:10.1542/peds.2011-3075
Accepted for publication Apr 23, 2012
Address correspondence to Herman Avner Cohen, MD, POB 187,
Yehud 56000 Israel. E-mail: hermanc@post.tau.ac.il
PEDIATRICS (ISSN Numbers: Print, 0031-4005; Online, 1098-4275).
Copyright © 2012 by the American Academy of Pediatrics
FINANCIAL DISCLOSURE: The authors have indicated they have
no nancial relationships relevant to this article to disclose.
FUNDING: This study was supported in part by a research grant
from the Israel Ambulatory Pediatric Association, Materna Infant
Nutrition Research Institute, and the Honey Board of Israel. The
funders had no role in the study design, data collection or
analysis, decision to publish, or preparation of the manuscript.
PEDIATRICS Volume 130, Number 3, September 2012 465
ARTICLE
by guest on October 21, 2015pediatrics.aappublications.orgDownloaded from
Cough is a common symptom in pedi-
atric practice. It can be particularly
troubling to children and their parents.
It often results in discomfort to the child
and loss of sleep for both the child and
parents. As a result, children miss day
care or school and parents miss a day of
work. In an attempt to treat cough,
caregivers frequently administer over-
the-counter (OTC) medications to their
children, with their attendant risks,
17
lack of proven efcacy,
811
and the dis-
approval of professional organizations
such as the American Academy of Pe-
diatrics,
12
and the Food and Drug Ad-
ministration (FDA).
13
A variety of home remedies and herbal
medications, such as licorice, cloves,
lemon, and honey, are used by some
caregivers to treat the symptoms as-
sociated with upper respiratory tract
infections (URIs).
14,15
The World Health
Organization has noted honey as a po-
tential treatment of cough and cold
symptoms, and it is considered as a de-
mulcent that is inexpensive, popular, and
safe (outside of the infant population).
14
Honey has antioxidant properties and
increases cytokine release, which may
explain its antimicrobial effects.
1621
The objective of this trial was to com-
pare the effects on nocturnal cough and
the sleep difculty associated with URIs
of a single nocturnal dose of 3 honey
products compared with placebo.
METHODS
Patients
Subjects were recruited from patients
who presented to 1 of 6 general pedi-
atric community clinics for an acute
care visit between January 2009 and
December 2009. Eligible patients were
those between the ages of 1 and 5 years
complaining of nocturnal cough that
was attributed to a URI. A URI was de-
ned by the presence of cough and
rhinorrhea of #7 daysduration. Other
symptoms might have included but were
not limited to nasal congestion, fever,
sore throat, myalgia, and headache.
Patients were excluded if they had signs
or symptoms of asthma, pneumonia,
laryngotracheobronchitis, sinusitis, and/
or allergic rhinitis. Patients were also
excluded if they had used any cough or
cold medication or honey on the night
before entering the study. Patients were
not excluded when analgesic medica-
tions such as acetaminophen or ibupro-
fenwereadministeredoneithernightof
the study.
Preintervention Study
Questionnaire
After attaining informed consent, all
participating parents were asked to
complete a 5-item questionnaire re-
garding their subjective assessments
of the childs cough and sleep difculty
on the previous night. The question-
naire used was a Hebrew version of a
previously validated questionnaire
22
(Fig 1). Survey responses were graded
on a 7-point Likert scale. Minimum
symptom severity score criteria were
established to determine which children
should enter the randomized trial. Only
children whose parents rated a severity
of at least 3 for a minimum of 2 of the 3
questions related to nocturnal cough
frequency, effect on the childssleep,and
effect on parental sleep on the previous
night were included.
Study Design
A double-blind randomized design was
used to conduct this study. Eligible
children were randomized to 4 treat-
ment groups: 3 groups were given1 of 3
types of honey (eucalyptus honey
(family Myrtaceae), labiatae honey
(family Labiatae ), or citrus hon ey (family
Rutaceae), or a placebo. Silan date ex-
tract was selected as the placebo be-
cause its structure, brown color, and
taste are similar to that of honey.
Intervention
The 3 honeys and the silan date extract
were prepared by the staff of the Zerin
Breeding Apiary of the Volcani Agri-
cultural Research Center in Rechovot,
Israel. All 3 types of honey and the silan
date extract were packed in small
plastic containers of 10 g each and
marked with the letters A, B, C, or D. The
study preparations were distributed to
the pediatric community clinics in
blocks of 4. Parents were instructed to
administer 10 g of their childs treat-
ment product within 30 minutes of the
child going to sleep. The parents were
instructed that the preparation could
be given undiluted or together with a
noncaffeinated beverage.
The parents, the physicians, and the
study coordinator did not know the
content of the preparation that was
dispensed. The envelopes containing
the codes of the study preparations
were stored at the ofce of the Ministry
of Agriculture, Extension Service, Bee-
keeping Department, and were not
opened until after the statistical anal-
ysis was completed.
Postintervention Study
Questionnaire
The day after the treatment, the parent
who completed the preintervention
questionnaire was contacted by tele-
phone. Trainedresearch assistants who
were blinded to the treatment group
FIGURE 1
CoughSeverity AssessmentQuestionnaire.Scoring:0 = not at all, 1 = not much, 2 = a little,3 = somewhat, 4 =
a lot, 5 = very much, 6 = extremely.
466 COHEN et al by guest on October 21, 2015pediatrics.aappublications.orgDownloaded from
asked the parent the same 5 questions
that had been answered in writing be-
fore the intervention, this time re-
garding the previous evening when the
child had received the treatment. No
physician examination was performed
on the second study day unless dictated
by illness progression.
Outcome Measures
The primary outcome was the cough
frequency. The primary outcome mea-
sure was the change in the frequency of
cough between the 2 nights. Secondary
outcome measures of importance were
changes in the cough severity, the both-
ersome nature of the cough, the effect of
the cough on sleep for both the child and
the parent, and the combined score of
these ve measures.
Sample Size Analysis
On the basis of previously published
data,
8
we estimated that the sample
size necessary to detect a 0.75-point dif-
ference between any 2 treatment groups
(using analysis of variance) with 90%
power and an aof .05 was 60 subjects
per treatment group.
Tocompen sate for possible dropouts and
abnormal data distribution, we attemp-
ted to recruit 75 patients per group.
Statistical Analysis
Statistical comparisons of variables
between treatment groups were per-
formed by using the x
2
test for nominal
variables and analysis of variance for
continuous variables. For comparisons
of cough evaluation before and after
treatment, a paired Student ttest was
used. A Pvalue ,.05 was considered
statistically signicant. All statistical
analyses were done by using the SPSS
package for Windows (version 15.0.1,
SPSS, Chicago, IL).
Ethics
The study was approved by the Com-
mittee for Ethics in Human Subjects
Research, Meir Medical Center, Kfar
Saba, Israel.
RESULTS
Three hundred children with URIs were
enrolled and 270 (89.7%) completed the
single-night study (Fig 2). Sixty-four
children received eucalyptus honey,
62 received citrus honey, 73 received
labiatae honey, and 71 received pla-
cebo (silan date extract). The dropout
rate was higher in the citrus and eu-
calyptus groups (P= .006).
The median age of the patients com-
pleting the study was 29 months (range
1271 months), with no signicant
difference in age among the treatment
groups (Table 1). One hundred forty-six
of the children (54%) were boys. The
participants were ill a mean 6SD of
2.8 62.0 days before enrollment, with
no signicant differences among treat-
ment groups (P= .161). Almost half
(47%) of the children had .3daysof
coughing, with no difference among
groups (P= .9). In addition, there were no
signicant differences between mea-
sures of symptom severity at baseline.
When symptom scores were compared
for each treatment group from the night
before treatment to the night of treat-
ment, signicant differences were de-
tected in the amount of improvement
reported for all study outcome varia-
bles (Fig 3). No signicant differences
were found among the different types
of honey; however, each of the honey
groups had a better response com-
pared with the silan date extract. For
cough frequency, those who received
eucalyptus honey had a mean 1.77-
point improvement compared with a
1.95-point change for those receiving
citrus honey, 1.82 change for those
receiving labiatae honey, and a 1.00
point change for those who were treated
with silan date extract (placebo group)
on the second night (F= 5.708, P,
.001). Parents also noted similar im-
provements in the severity of their
childs cough: 1.78 points with eucalyptus
honey, 1.77 points with citrus honey, 1.94
points with labiatae honey and 0.99
points with silan date extract (F=5.78,
P,.001). Parents felt the cough also
was less bothersome on the second
night, with honey providing the greatest
relief with a 2.0-point change with euca-
lyptus honey, a 2.16-point change with
citrus honey, and a 2.07-point change
with labiatae honey, compared with
a 1.25-point change with silan date
extract group (F=4.63,P,.04). Parents
rated their childrens sleep better after
receiving honey, with improvement by
2.13 points with eucalyptus honey, 1.98
points improvement with citrus honey,
and 1.70 points with labiatae honey,
compared with a 1.21-point change
with silan date extract (F= 3.61, P,
.014). As might be expected, parental
sleep improved in a fashion similar to
that of their children, with the honey-
treatment arms improving the most,
a mean of 2.16 points with eucalyptus
honey, 2.10 points with citrus honey,
1.90 points with labiatae honey, and
1.28 points with silan date extract (F=
3.40, P,.018). When the results for
these outcomes were combined by add-
ing the scores from the individual cate-
gories, honey again proved to be the
most effective treatment. The children
improved by an average of 9.88 points
with eucalyptus honey, 10.10 points with
citrus honey, 9.51 points with labiatae
honey, compared with 5.82 points for
those treated with silan date extract (F=
5.33, P,.001).
Stomachache, nausea, or vomiting were
reported by the parents of 4 patients in
the honey treatment group (2 in the citrus,
1 in the eucalyptus, and 1 in the labiatae
honey group) and 1 in the placebo group.
The adverse events were not signicantly
different between the groups.
DISCUSSION
The results of this study (Fig 3) dem-
onstrate that each of the 3 types of
ARTICLE
PEDIATRICS Volume 130, Number 3, September 2012 467
by guest on October 21, 2015pediatrics.aappublications.orgDownloaded from
honey (eucalyptus, citrus, and labiatae)
was more effective than the placebo for
the treatment of all of the outcomes
related to nocturnal cough, child sleep,
and parental sleep.
The results of our study strengthen the
observation made by Paul et al
8
that
honey products may have a benecial
effect for symptomatic relief of noc-
turnal cough associated with URIs. Our
study differs, however, from the study of
Paul et al because they compared the
effect of 1 type of honey (buckwheat) to
dextromethorphan and a no-treatment
group, whereas our study compared
the effectiveness of 3 types honey to
placebo.
In contrast with Paul et al, we did not
document symptoms of hyperactivity,
nervousness, and insomnia in the honey
treatment groups versus the placebo
group. Shadkam et al
23
also reported
that honey had a more alleviating effect
on URI-induced cough compared with
dextromethorphan and diphenhydramine.
That study was not blinded, however.
Thus, our study further supports the
recommendations of the World Health
Organization to use honey as a poten-
tial treatment of cough.
14
Honey is a remarkably complex natural
liquid that is reported to contain at least
181 substances.
24
It has well-established
antioxidant and antimicrobial effects
FIGURE 2
Patient ow diagram.
TABLE 1 Baseline Patient Characteristics by Group
Characteristic A (n= 64) B (n= 62) C (n= 73) D (n= 71) PValue
Age in months (mean 6SD) 27.5 613.9 29 613.5 30 616.6 29 614.9 .235
Male gender
Number (%) 36 (56) 26 (36) 39 (53) 23 (32) .018
Days of illness (mean 6SD) 2.4 61.4 3.5 63.1 2.7 61.6 2.7 61.8 .16
Cough frequency score
(mean 6SD)
3.72 61.02 3.76 61.14 3.68 60.9 3.58 60.82 .73
Cough severity score (mean 6SD) 3.66 60.96 3.71 61.08 3.75 60.91 3.55 60.77 .59
Cough bother score (mean 6SD) 3.78 61.15 3.85 61.13 3.85 61.05 3.70 61.07 .84
Child sleep score (mean 6SD) 3.72 61.40 3.61 61.31 3.49 61.32 3.69 61.19 .74
Parental sleep score (mean 6SD) 3.75 61.60 3.66 61.38 3.75 61.26 3.70 61.35 .98
Combined symptom score
(mean 6SD)
18.63 65.62 18.60 65.00 18.48 64.59 18.23 64.55 .96
A, eucalyptus honey; B, citrus honey; C, labiatae honey; D, silan date extract.
468 COHEN et al by guest on October 21, 2015pediatrics.aappublications.orgDownloaded from
that have been suggested as the mech-
anism for honeysefcacy in wound
healing and may help to explain its su-
perior results in this study.
1621
The antioxidants present in honey come
from a variety of sources, such as vi-
tamin C, monophenolics, avonoids,
and polyphenolics. Although there is a
wide spectrum of antioxidant types,
monophenolics such as 4-hydroxybenzoic
and 4-hydroxycinnamic acids predom-
inate in many honeys.
21,25
Most of the
antioxidant components in processed
honey are water, not lipid, soluble.
21
Different types of honey vary widely in
the quantity of water-soluble antioxi-
dants they contain.
26,27
This variability
is dependent on the honeysoral source,
as well as seasonal, environmental, and
other external factors. It was observed
that the darker a honeys color, the
higher its antioxidant capacity. The
levels of certain antioxidant compo-
nents decrease with processing and
storage of honey.
21
However, available
data show that phenolic antioxidants
from processed honey are bioavailable
and increase the antioxidant activity of
plasma.
19
Eccles
26
provided another possible ex-
planation for some of the benecial
effects of honey. Because of the close
anatomic relationship between the
sensory nerve bers that initiate cough
and the gustatory nerve bers that
taste sweetness, an interaction be-
tween these bers may produce an
antitussive effect of sweet substances
via a central nervous system mecha-
nism. This theory may explain some of
the observed effect in patients treated
with silan date extract because this
is also a sweet substance. However,
the signicant difference between the
honey products and the silan date ex-
tract suggests that other factors in
addition to the sweet taste of honey
contribute to its benecial effect on
children with cough.
Silan was used as placebo in this study.
An alternative hypothesis is that silan
date extract could worsen cough and
cold symptoms. However, our data
clearly show that patients treated with
silan date extract actually improved.
There is also no reason to believe silan
caused allergic symptoms or bron-
chospasm because dates are not a
common food allergen in the Israeli
population.
27
FIGURE 3
The effect of different types of honey and silan date extract on cough frequency (I), cough severity (II), cough bothersome to child (III), the childs sleep (IV),
parents sleep (V), and combined symptoms score (VI). P,.05 for the comparisons between group D and the other groups. A, eucalyptus honey; B, citrus
honey; C, labiatae honey; D, silan date extract.
ARTICLE
PEDIATRICS Volume 130, Number 3, September 2012 469
by guest on October 21, 2015pediatrics.aappublications.orgDownloaded from
Cough due to a viral URI is generally self-
limited. However, parents often wish
some active intervention. This tends to
lead to the use of OTC cough medi-
cations. However, these medications
are potentially dangerous. Many of the
adverse events reported were caused
by inadvertent overdoses when parents
gave the drug to a child too often or at
a higher than recommended dose.
Some overdoses were caused when the
parents gave a child a combination
of cold and cough medicines, not re-
alizing the product containing the same
ingredient.
Dart et al
28
reported 118 cases of fatal-
ities in children younger than 12 years
of age that were judged as possibly,
likely, or denitely related to a cough
and cold ingredient. Of these 118 cases,
103 involved a nonprescription medica-
tion, and the ingredients most often
mentioned were pseudoephedrine (n=
45), diphenhydramine (n=38),and
dextromethorphan (n= 36). Of these
cases, the evidence indicated that 88
involved an overdose. Several contrib-
uting factors were identied, age ,2
years, use of medication for sedation,
use in day-care settings, use of 2
medicines with the same ingredient,
failure to use a measuring device,
product misidentication, and use of
a nonprescription product intended
for adult use.
Rimsza et al reported 10 unexpected
deaths that were associated with the
use of OTC cough and cold medications
in a 1-year period.
29
The authors rec-
ommended that such medications
should not be given to infants because
they may present a serious health
hazard, and there is no evidence to
support the efcacy and safe dosage of
these medications in infants. Rimsza
et al also suggest that educational
campaigns to decrease the use of OTC
cough and cold medications in infants
need to be increased.
29
Lokker et al reported that unintentional
misuse of OTC cold products is common
and could result in harm if medications
are given inappropriately. Label lan-
guage and graphics seem to inuence
inappropriate interpretation of OTC
product age indications.
30
As a result of
these studies, an FDA advisory com-
mittee recommended against the use
of OTC cough and cold medications in
children aged ,6 years, and a sub-
sequent FDA public health advisory was
issued recommending against the use
of these medications in children ,2
years of age.
13
Honey is an alternative that is generally
regarded as safe for children older
than 1 year. Allan et al
31
stated that
evidence for honey in acute pediatric
cough supports a small effect, but
clinical signicance is uncertain. Our
randomized, placebo-controlled study
seems to indicate that treatment with
honey can be clinically effective.
We suggest, in concordance with the
FDA
13
and the Israeli Ministry of Health
Pharmaceutical Administration, that
caregivers and clinicians should be
aware of the risk of serious adverse
events from administering cough and
cold medications to children ,2 years
of age and use several precautions
when using them in older children (2
11 years). We believe that educational
campaigns to decrease the use of OTC
cough and cold medications in children
need to be increased. On the basis of
our ndings, honey can be offered as
an alternate treatment to children .1
year of age. Honey should not be given
to children ,1 year of age because of
the risk of infantile botulism.
32
Because
frequent use of honey can cause dental
caries, the recommendation should be
for a short course of honey.
The study is limited by the subjective
nature of the survey used. However,
clinicians and parents often make de-
cisions based on subjective assess-
ments of symptom severity. It should
also be noted that it is possible that
some of the improvement measured
could also be attributed to the nat-
ural history of URIs, which generally
improve with time and supportive
care.Furthermore,compliancewith
honey and placebo administration
could not be guaranteed. However,
every parent reported that their child
took the treatment as recommended.
Another limitation is the fact that the
effect of only a single dose was
evaluated. If the intervention period
would have been longer and more
than 1 dose given, the results would
have been more reliable and more
valuable.
The dropout rate was higher for chil-
dren receiving citrus and eucalyptus
honey. The exact reason for the higher
dropout rate in these groups is not
known. Because these types of honey
are more aromatic, it is possible that
some children disliked the honey
taste.
CONCLUSIONS
Parents rated each of the honey prod-
ucts more favorably than the silan
date extract for symptomatic relief of
their childrens nocturnal cough and
sleep difculty due to URI. Honey may
be a preferable treatment of cough
and sleep difculties associated with
childhood URI. In light of this study,
honey can be considered an effective
and safe treatment of children .1 year
of age.
ACKNOWLEDGMENT
We thank Dorit Krash of Clalit Health
Services for statistical analysis.
470 COHEN et al by guest on October 21, 2015pediatrics.aappublications.orgDownloaded from
REFERENCES
1. Kuehn BM. FDA: cold medications risky for
young children. JAMA. 2007;298(10):1151
2. Warden CR, Diekema DS, Robertson WO.
Dystonic reaction associated with dextro-
methorphan ingestion in a toddler. Pediatr
Emerg Care. 1997;13(3):214215
3. Centers for Disease Control and Prevention
(CDC). Infant deaths associated with cough
andcoldmedicationstwo states, 2005.
MMWR Morb Mortal Wkly Rep. 2007;56(1):14
4. Gun VL, Taha SH, Liebelt EL, Serwint JR.
Toxicity of over-the-counter cough and cold
medications. Pediatrics. 2001;108(3). Avail-
able at: www.pediatrics.org/cgi/content/full/
108/3/e52
5. Watson WA, Litovitz TL, Rodgers GC Jr, et al.
2004 Annual report of the American Asso-
ciation of Poison Control Centers Toxic Ex-
posure Surveillance System. Am J Emerg
Med. 2005;23(5):589666
6. Marinetti L, Lehman L, Casto B, Harshbarger
K, Kubiczek P, Davis J. Over-the-counter cold
medicationspostmortem ndings in in-
fants and the relationship to cause of death.
J Anal Toxicol. 2005;29(7):738743
7. Pen de r ES , Parks BR . Tox ic it y with
dextromethorphan-containing preparations:
a literature review and report of two addi-
tional cases. Pediatr Emerg Care. 1991;7(3):
163165
8. Paul IM, Beiler J, McMonagle A, Shaffer ML,
Duda L, Berlin CM Jr. Effect of honey dex-
tromethorphan, and no treatment on noc-
turnal cough and sleep quality for coughing
children and their parents. Arch Pediatr
Adolesc Med. 2007;161(12):11401146
9. Paul IM, Yoder KE, Crowell KR, et al. Effect of
dextromethorphan, diphenhydramine, and
placebo on nocturnal cough and sleep quality
for coughing children and their parents.
Pediatrics. 2004;114(1). Available at: www.
pediatrics.org/cgi/content/full/114/1/e85
10. Warren MD, Pont SJ, Barkin SL, et al. The
effect of honey on nocturnal cough and
sleep quality for children and their parents.
Arch Pediatr Adolesc Med. 2007;161(12):
11491153
11. Yoder KE, Shaffer ML, La Tournous SJ, Paul
IM. Child assessment of dextromethorphan,
diphenhydramine, and placebo for noc-
turnal cough due to upper respiratory
infection. Clin Pediatr (Phila). 2006;45(7):
633640
12. American Academy of Pediatrics, Committee on
Drugs. Use of codeine- and dextromethorphan-
containing cough remedies in children. Pe-
diatrics. 1997;99(6):918920
13. Food and Drug Administration. FDA releases
recommendati ons re gard ing use of over-
the-counter cough and cold products.
January 17, 2008. Available at: www.fda.
gov/bbs/topics/NEWS/2008/NEW01778.html.
Accessed May 12, 2011
14. Department of Child and Adolescent Health.
Cough and cold remedies for the treatment
of acute respiratory infections in young
children. Geneva, Switzerland: World Health
Organization 2001
15. Ziment I. Herbal antitussives. Pulm Phar-
macol Ther. 2002;15(3):327333
16. Wahdan HA. Causes of the antimicrobial
activity of honey. Infection. 1998;26(1):2631
17. Lusby PE, Coombes AL, Wilkinson JM. Bac-
tericidal activity of different honeys against
pathogenic bacteria. Arch Med Res. 2005;36
(5):464467
18. Adeleye IA, Opiah L. Antimicrobial activity of
extracts of local cough mixtures on upper
respiratory tract bacterial pathogens. West
Indian Med J. 2003;52(3):188190
19. Schramm DD, Karim M, Schrader HR, Holt
RR, Cardetti M, Keen CL. Honey with high
levels of antioxidants can provide pro-
tection to healthy human subjects. J Agric
Food Chem. 2003;51(6):17321735
20. Tonks AJ, Cooper RA, Jones KP, Blair S,
Parton J, Tonks A. Honey stimulates inam-
matory cytokine production from monocytes.
Cytokine. 2003;21(5):242247
21. Gheldof N, Wang XH, Engeseth NJ. Identi-
cation and quantication of antioxidant
components of honeys from various oral
sources. J Agric Food Chem. 2002;50(21):
58705877
22. Hartnick CJ, Zurakowski D, Haver K. Vali-
dation of a pediatric cough questionnaire.
Ear Nose Throat J. 2009;88(11):12131217
23. Shadkam MN, Mozffari-Khosravi H, Moyazan
MR. A comparison of the effect of honey,
dextromethorphan, and diphenhydramine
on nightly cough and sleep quality in chil-
dren and their parents. J Altern Comple-
ment Med. 2010;6(7):787793
24. White JW. Composition of honey. In Crabe E,
ed. Honey: A Comprehensive Survey. New
York, NY: Crane, Russak Company; 1975;
157206
25. Gheldof N, Engeseth NJ. Antioxidant capac-
ity of honeys from various oral sources
based on the determination of oxygen
radical absorbance capacity and inhibition
of in vitro lipoprotein oxidation in human
serum samples. J Agric Food Chem. 2002;
50(10):30503055
26. Eccles R. Mechanisms of the placebo effect
of sweet cough syrups. Respir Physiol
Neurobiol. 2006;152(3):340348
27. Kornizky Y, Topilsky M, Fireman E, Kivity
S, Kivity S. Specic IgE antibodies to aer-
oallergens and food among Israelis. Ann
Allergy Asthma Immunol. 1999;83(2):149
152
28. Dart RC, Paul IM, Bond GR, et al. Pediatric
fatalities associated with over the counter
(nonprescription) cough and cold medi-
cations. Ann Emerg Med. 2009;53(4):411
417
29. Rimsza ME, Newberry S. Unexpected infant
deaths associated with use of cough and
cold medications. Pediatrics. 2008;122(2).
Available at: www.pediatrics.org/cgi/content/
full/122/2/e318
30. Lokker N, Sanders L, Perrin EM, et al. Pa-
rental misinterpretations of over-the-counter
pediatric cough and cold medication labels.
Pediatrics . 2009;123(6):14641471
31. Allan GM, Korownyk C, Kolber M. Do cough
suppressants or honey help pediatric cough?
Can Fam Physician. 2011;57(4):435
32. Cox N, Hinkle R. Infant botulism. Am Fam
Physician. 2002;65(7):13881392
ARTICLE
PEDIATRICS Volume 130, Number 3, September 2012 471
by guest on October 21, 2015pediatrics.aappublications.orgDownloaded from
DOI: 10.1542/peds.2011-3075
; originally published online August 6, 2012; 2012;130;465Pediatrics
Yosef Uziel, Eran Kozer, Avishalom Pomeranz and Haim Efrat
Herman Avner Cohen, Josef Rozen, Haim Kristal, Yoseph Laks, Mati Berkovitch,
Randomized, Placebo-Controlled Study
Effect of Honey on Nocturnal Cough and Sleep Quality: A Double-blind,
Services
Updated Information &
ml
http://pediatrics.aappublications.org/content/130/3/465.full.ht
including high resolution figures, can be found at:
References
ml#ref-list-1
http://pediatrics.aappublications.org/content/130/3/465.full.ht
at:
This article cites 28 articles, 7 of which can be accessed free
Citations
ml#related-urls
http://pediatrics.aappublications.org/content/130/3/465.full.ht
This article has been cited by 6 HighWire-hosted articles:
Subspecialty Collections
_tract_sub
http://pediatrics.aappublications.org/cgi/collection/respiratory
Respiratory Tract
the following collection(s):
This article, along with others on similar topics, appears in
Permissions & Licensing
tml
http://pediatrics.aappublications.org/site/misc/Permissions.xh
tables) or in its entirety can be found online at:
Information about reproducing this article in parts (figures,
Reprints http://pediatrics.aappublications.org/site/misc/reprints.xhtml
Information about ordering reprints can be found online:
rights reserved. Print ISSN: 0031-4005. Online ISSN: 1098-4275.
Grove Village, Illinois, 60007. Copyright © 2012 by the American Academy of Pediatrics. All
and trademarked by the American Academy of Pediatrics, 141 Northwest Point Boulevard, Elk
publication, it has been published continuously since 1948. PEDIATRICS is owned, published,
PEDIATRICS is the official journal of the American Academy of Pediatrics. A monthly
by guest on October 21, 2015pediatrics.aappublications.orgDownloaded from
DOI: 10.1542/peds.2011-3075
; originally published online August 6, 2012; 2012;130;465Pediatrics
Yosef Uziel, Eran Kozer, Avishalom Pomeranz and Haim Efrat
Herman Avner Cohen, Josef Rozen, Haim Kristal, Yoseph Laks, Mati Berkovitch,
Randomized, Placebo-Controlled Study
Effect of Honey on Nocturnal Cough and Sleep Quality: A Double-blind,
http://pediatrics.aappublications.org/content/130/3/465.full.html
located on the World Wide Web at:
The online version of this article, along with updated information and services, is
of Pediatrics. All rights reserved. Print ISSN: 0031-4005. Online ISSN: 1098-4275.
Boulevard, Elk Grove Village, Illinois, 60007. Copyright © 2012 by the American Academy
published, and trademarked by the American Academy of Pediatrics, 141 Northwest Point
publication, it has been published continuously since 1948. PEDIATRICS is owned,
PEDIATRICS is the official journal of the American Academy of Pediatrics. A monthly
by guest on October 21, 2015pediatrics.aappublications.orgDownloaded from
... Various studies have shown honey to be effective against cough. It reduces the frequency and severity of cough and improves the sleep quality of children having cough [4] . ...
Article
Full-text available
Urbanization has increased the risk of respiratory diseases in adults and children. Various medicines help deal with the symptoms associated with common respiratory conditions like the common cold, cough, sore throat, si-nusitis, asthma, bronchitis, COPD, and a few more. However, many herbs are used traditionally to manage these conditions, such as Tulsi, Mulethi, Ginger, Motha, Talispatra, Peppermint, Ashwagandha, Pippali, Rudravanti, Bhumi amla, Fennel, Adulsa, Vacha, Thyme and a lot more due to their safety profile and preferences. A decoc-tion of honey and herbs is well known for managing respiratory conditions.
... It is known in our societies that honey is an essential healthy food substance in the treatment and prevention of many diseases, and in fact, its health benefit has been scientifically proven in many studies in treating infections and reducing the risk of cardiovascular diseases by improving lipid profile [18], obesity management [19], glucose tolerance in diabetic patients [20] and many more. In children, in particular, it is mainly used to treat nocturnal cough and urinary tract infections and to improve sleep quality [21][22][23]. It also has a rule in gastroenteritis treatment by using it as a substitute for glucose in the oral rehydration solution [24]. ...
Article
Full-text available
Background Although nutritionally beneficial, honey may harbor Clostridium botulinum spores, posing risks to infant botulism (IB). Infants under one year are vulnerable due to immature gut flora, with IB potentially causing severe symptoms, such as respiratory failure. Despite global awareness, cultural beliefs influenced caregivers’ practices in Palestine. This study evaluated Palestinian parents’ knowledge, beliefs, and feeding practices regarding honey to guide targeted interventions. Methods This cross-sectional study (August–September 2024) surveyed 469 Palestinian parents (aged ≥18 years) from 10 West Bank cities, excluding 88 ineligible responses. A validated questionnaire assessed their knowledge, attitudes, and practices. Data were analyzed using the R software (frequency, Chi-squared/Fisher’s tests; p < 0.05). Results Most participants were female (89%), under 30 years old (53%), and highly educated (77%). While 58% knew of honey-linked IB, only 32% identified C. botulinum as the causative agent. Notably, 15.8% fed honey to infants aged <12 months and 62.5% introduced complementary feeding at 6–12 months. Age and income-influenced practices, with many believing that honey aids digestion or supplements nutrition. Conclusions The findings reveal gaps in knowledge and widespread cultural beliefs about the benefits of honey, which contribute to unsafe feeding practices. Health interventions in Palestine should incorporate these insights to improve awareness and to prevent IB.
... It is known in our societies that honey is an essential healthy food substance in the treatment and prevention of many diseases, and in fact, its health benefit has been scientifically proven in many studies in treating infections and reducing the risk of cardiovascular diseases by improving lipid profile [18], obesity management [19], glucose tolerance in diabetic patients [20] and many more. In children, in particular, it is mainly used to treat nocturnal cough and urinary tract infections and to improve sleep quality [21][22][23]. It also has a rule in gastroenteritis treatment by using it as a substitute for glucose in the oral rehydration solution [24]. ...
Article
Full-text available
Background: Although nutritionally beneficial, honey may harbor Clostridium botulinum spores, posing risks to infant botulism (IB). Infants under one year are vulnerable due to immature gut flora, with IB potentially causing severe symptoms, such as respiratory failure. Despite global awareness, cultural beliefs influenced caregivers’ practices in Palestine. This study evaluated Palestinian parents’ knowledge, beliefs, and feeding practices regarding honey to guide targeted interventions. Methods: This cross-sectional study (August–September 2024) surveyed 469 Palestinian parents (aged ≥18 years) from 10 West Bank cities, excluding 88 ineligible responses. A validated questionnaire assessed their knowledge, attitudes, and practices. Data were analyzed using the R software (frequency, Chi-squared/Fisher’s tests; p < 0.05). Results: Most participants were female (89%), under 30 years old (53%), and highly educated (77%). While 58% knew of honey-linked IB, only 32% identified C. botulinum as the causative agent. Notably, 15.8% fed honey to infants aged <12 months and 62.5% introduced complementary feeding at 6–12 months. Age and income-influenced practices, with many believing that honey aids digestion or supplements nutrition. Conclusions: The findings reveal gaps in knowledge and widespread cultural beliefs about the benefits of honey, which contribute to unsafe feeding practices. Health interventions in Palestine should incorporate these insights to improve awareness and to prevent IB.
... Generally, the parents noted that honey was more effective than silan extract in relieving cough symptoms and sleep difficulties. Honey may be a preferable treatment for symptoms associated with childhood acute upper respiratory infections [13]. ...
Article
Full-text available
Background In the context of complementary medicine, honey is a product used alongside conventional medical treatments or therapies to enhance their effectiveness or provide additional benefits. Honey has been used for centuries in traditional and complementary medicine for its various health-promoting properties. Objectives The aim of this systematic review was to analyze studies on the therapeutic use of honey in acute respiratory infections (ARI) and exacerbations of chronic diseases (ECD), and to compare the effect of honey with other traditional treatments/remedies. Methods literature searches on PubMed, Medline, Scopus, ScopeMed, and Google Scholar were performed to discover the current state of knowledge on the subject and recent publications. Variables were analysed using the full meta-analysis software, version 3 (Biostat, NJ, USA). Variables were analysed to calculate the odds ratio (OR) and standardised mean difference for dichotomous and continuous variables, respectively. Corresponding 95% confidence intervals for effect sizes were also calculated using a fixed-effects model. Mantel-Haenszelen random-effects models were used due to the large number of articles and the presence of significant heterogeneity. Heterogeneity was considered significant with an I2 value greater than 50% or a P value less than 0.01. Results We found that honey seems to improve symptoms in both children and adults. Studies used from the literature search comprised 43% of pediatric studies; 26% were in an ambulatory setting; 9% were in surgical and 22% were medical. The results showed that honey was associated with a significantly greater reduction in the combined cough symptom score, frequency, and severity of acute infections, and an improvement in forced vital capacity, forced expiratory volume, peak expiratory flow, and respiratory symptoms for exacerbations of chronic diseases. Most of the studies reviewed were less than 10 years old; the comparison of the risk of bias between the studies showed that 48% of the studies on ARI (acute respiratory infections) had a low risk of bias, while this percentage was higher for the studies on exacerbations of chronic diseases (ECD) (68%). Conclusion Honey probably improves symptoms of respiratory infections, so it is recommended that honey may be a supplement to usual medicines and treatments.
... Periodic studies have demonstrated the effectiveness of honey in reducing the frequency of cough, including night cough in children with respiratory infections (34,(52)(53)(54). Meta-analyses have also shown that the use of honey after tonsillectomy can lead to reduced pain and improved wound healing, as well as reduced discomfort caused by the wounds. ...
Article
Full-text available
Cough is one of the most prevalent symptoms of COVID-19, affecting over 60% of patients. This symptom significantly diminishes quality of life, causing fatigue, insomnia, dysphonia, musculoskeletal pain, and urinary incontinence. Honey Zufa herbal syrup is a well-known antitussive remedy in the Iranian market and was evaluated for its potential to alleviate this symptom. This study aimed to assess the efficacy and safety of Honey Zufa herbal syrup in treating acute cough resulting from mild to moderate COVID-19. A randomized controlled trial was conducted with 200 patients assigned to either the treatment group, receiving Honey Zufa herbal syrup, or the placebo group, receiving a placebo. Both groups also received standard cough control medications. Cough severity was measured using three different scoring systems. The impact of Honey Zufa on cough severity, the influence of other medications, and changes in laboratory parameters were monitored over a 14-day period. Honey Zufa herbal syrup significantly reduced cough severity compared to the placebo across all scoring systems. The treatment group experienced a greater reduction in cough severity than the placebo group. However, there was no significant difference between the groups in terms of antitussive medication regimens. Laboratory parameters remained stable, and no significant side effects were observed. Honey Zufa herbal syrup effectively reduces cough severity in patients with mild to moderate COVID-19, suggesting it could serve as a useful complementary and alternative treatment option for COVID-19-induced cough.
... Lowers blood sugar and cholesterol. Fenugreek contains compounds that enhance the other herbs' effects on insulin sensitivity and lipid metabolism [166] 18 Allium sativum L. ...
Article
Full-text available
Background The use of herbal medicines is on the rise throughout the world due to their perceived safety profile. However, incidences of herb-drug, herb-herb and herb-food interactions considering safety aspects have opened new arenas for discussion. Objective The current study aims to provide comprehensive insights into the various types of herb interactions, the mechanisms involved, their assessment, and historical developments, keeping herbal safety at the central point of discussion. Methods The authors undertook a focused/targeted literature review and collected data from various databases, including Science Direct, Wiley Online Library, Springer, PubMed, and Google Scholar. Conventional literature on herbal remedies, such as those by the WHO and other international or national organizations. Results The article considered reviewing the regulations, interaction mechanisms, and detection of herb-herb, herb-drug and herb-food interactions in commonly used yet vital plants, including Glycyrrhiza glabra, Mentha piperita, Aloe barbadensis, Zingiber officinale, Gingko biloba, Withania somnifera, etc. The study found that healthcare professionals worry about patients not informing them about their herbal prescriptions (primarily used with conventional treatment), which can cause herb-drug/herb-food/herb-herb interactions. These interactions were caused by altered pharmacodynamic and pharmacokinetic processes, which might be explained using in-vivo, in-vitro, in-silico, pharmacogenomics, and pharmacogenetics. Nutrivigilance may be the greatest method to monitor herb-food interactions, but its adoption is limited worldwide. Conclusion This article can serve as a lead for clinicians, guiding them regarding herb-drug, herb-food, and herb-herb interactions induced by commonly consumed plant species. Patients may also be counseled to avoid conventional drugs, botanicals, and foods with a restricted therapeutic window.
... The dataset covers a diverse range of medical indications exploring honey as a potential remedy. This distribution is shown in Figure 3. , oncology (17 studies) [108][109][110][111][112][113][114][115][116][117][118][119][120][121][122][123][124], respiratory conditions (13 studies) [125][126][127][128][129][130][131][132][133][134][135][136][137], oral health (14 studies) [138][139][140][141][142][143][144][145][146][147][148][149][150][151], surgery (11 studies) [152][153][154][155][156][157][158][159][160][161][162], gastrointestinal disorders (8 studies) [163][164][165][166][167][168][169][170], urogenital disorders (7 studies) [171][172][173][174][175][176][177], dermatology (6 studies) [178][179][180][181][182][183], sleep-related topics (6 stud- ies) [184][185][186][187][188][189], ophthalmology (5 studies) [190][191][192][193][194], neurocognitive issues (2 studies) [195,196] and hematology (1 study) [197]. ...
Article
Full-text available
Nowadays, in people’s perceptions, the return to roots in all aspects of life is an increasing temptation. This tendency has also been observed in the medical field, despite the availability of high-level medical services with many years of research, expertise, and trials. Equilibrium is found in the combination of the two tendencies through the inclusion of the scientific experience with the advantages and benefits provided by nature. It is well accepted that the nutritional and medicinal properties of honey are closely related to the botanical origin of the plants at the base of honey production. Despite this, people perceive honey as a natural and subsequently a simple product from a chemical point of view. In reality, honey is a very complex matrix containing more than 200 compounds having a high degree of compositional variability as function of its origin. Therefore, when discussing the nutritional and medicinal properties of honey, the importance of the geographical origin and its link to the honey’s composition, due to potential emerging contaminants such as Rare Earth Elements (REEs), should also be considered. This work offers a critical view on the use of honey as a natural superfood, in a direct relationship with its botanical and geographical origin.
... As evidenced by some previous studies, honey products may have a beneficial effect for symptomatic relief of coughing, even nocturnal coughing, associated with upper respiratory tract infections. 4,25,27,28 Mucilaginous polysaccharide-containing plants are widely used for therapeutic treatment of irritations of mucous membranes in the pharynx regions. In addition to the demulcent activity of honey, these polysaccharides adhere to the oral and pharynx mucosa and exert a mechanical barrier effect. ...
Article
Full-text available
The aim of this trial was to assess the effectiveness of Sediflù, a medical device containing active herbal ingredients, on nocturnal and diurnal persistent coughs in children, with a duration of 3 to 7 days. Children with a dry and/or productive cough were enrolled in this prospective, interventional, multicenter, placebo-controlled, double-blind, randomized clinical study. Clinical efficacy was assessed through the evaluation of the soothing action of Sediflù against dry and/or productive coughing, both at night and during the day, and other effects of coughing associated with quality of sleep: frequency, child’s quality of sleep, parental quality of sleep and severity. Treatment with Sediflù improved both night-time and day-time cough scores from day 2. The diurnal score also improved significantly in the Sediflù group at days 3 and 7. Sediflù syrup can be considered a valid treatment for cough management in younger children with upper respiratory tract infections, shortening the cough duration.
Article
Full-text available
Honey is an attractive functional food that often becomes a subject of clinical studies on the treatment of diverse diseases. However, the clinical efficacy of honey is rather controversial due, at least in part, to its variable composition and botanical origin as well as thermal processing or improper storage conditions. This review addresses the importance of honey quality standards and in vitro testing of the biological properties of honey prior to performing clinical studies, which can have a great impact on clinical outcomes. It focused on recently performed meta-analyses and systematic reviews where honey was used in the management of various disorders including respiratory tract infections, and metabolic and cardiometabolic diseases, with the goal of characterising the honeys used in clinical studies. In addition, it provides recommendations for the use and storage of honey for clinical testing. The vast majority of clinical studies included in meta-analyses do not provide any information about honey quality parameters. In fact, indicators of thermal damage or prolonged storage of honey were analysed only in one clinical study. This observation highlights on the alarming status of honey quality in clinical studies. Furthermore, in vitro biological properties of the analysed honeys were assessed in two clinical studies. Therefore, this review strongly advocates the clinical use of only fully characterised honey samples of known botanical origin with proven in vitro biological functionality and no or minimal thermal processing.
Article
Full-text available
Our study aimed to analyze five monovarietal honeys from the Salah Eddine region in Iraq, focusing on physicochemical, antioxidant, and antimicrobial properties and polyphenolic compounds. Our objective was to evaluate the strengths and qualities of Iraqi honeys, ensuring compliance with the Codex Alimentarius standard for honey. The spectrophotometric analysis included assessments of reduced sugar (75.8–77.7%), fructose-to-glucose ratio (0.7–0.9%), sucrose (2.2–2.9%), HMF (17.23–18.87 mg/kg), and melanoidin content (0.25–0.44), which were all determined. The electrical conductivity (0.39–0.46 mS/cm) using a conductivity meter, pH (4.02–4.31), and mineral composition were determined in all samples using atomic absorption spectrometry. Antioxidant activities were spectrophotometrically determined, through DPPH free radical scavenging (7.87–95.62 mg/mL), as was the total antioxidant activity (14.26–22.15 mg AAE/g), with correlations established with biochemical constituents such as the total phenol content, highlighting the significant presence of Coumaric acid (0.38–2.34 µg/mL), Catechin (1.80–2.68 µg/mL), and Quercetin (0.30 µg/mL) using HPLC. The study also observed notable antimicrobial activities using Escherichia coli, Staphylococcus aureus, and Candida albicans on Mueller–Hinton agar as well as through diffusion technique. In conclusion, our findings, including the antioxidant and antimicrobial strengths, underscore the substantial potential of Iraqi honeys in mitigating damage and preventing the onset of various diseases, affirming their good quality and adherence to international honey standards.
Article
Full-text available
Objectives. To determine whether the commonly used over-the-counter medications dextromethorphan and diphenhydramine are superior to placebo for the treatment of nocturnal cough and sleep difficulty associated with upper respiratory infections and to determine whether parents have improved sleep quality when their children receive the medications when compared with placebo. Methods. Parents of 100 children with upper respiratory infections were questioned to assess the frequency, severity, and bothersome nature of the nocturnal cough. Their answers were recorded on 2 consecutive days, initially on the day of presentation, when no medication had been given the previous evening, and then again on the subsequent day, when either medication or placebo was given before bedtime. Sleep quality for both the child and the parent were also assessed for both nights. Results. For the entire cohort, all outcomes were significantly improved on the second night of the study when either medication or placebo was given. However, neither diphenhydramine nor dextromethorphan produced a superior benefit when compared with placebo for any of the outcomes studied. Insomnia was reported more frequently in those who were given dextromethorphan, and drowsiness was reported more commonly in those who were given diphenhydramine. Conclusions. Diphenhydramine and dextromethorphan are not superior to placebo in providing nocturnal symptom relief for children with cough and sleep difficulty as a result of an upper respiratory infection. Furthermore, the medications given to children do not result in improved quality of sleep for their parents when compared with placebo. Each clinician should consider these findings, the potential for adverse effects, and the individual and cumulative costs of the drugs before recommending them to families.
Article
Full-text available
We conducted a study to determine if a five-item pediatric cough questionnaire (PCQ) is a valid and reliable means of measuring cough-specific quality of life in children. The five questions, which are answered by the child's parent or caregiver, cover cough frequency (Q1), sleep disturbance of the child (Q2), sleep disturbance of the parent (Q3), cough severity (Q4), and the degree of bothersomeness to the child (Q5). Each of the five items was scored on a 6-point Likert scale. The PCQ was administered three times. The first occurred when the parent telephoned to schedule an appointment for the child at a pediatric pulmonology outpatient clinic for a chief complaint of cough. The second PCQ was administered within 2 weeks of the first but before any treatment had been instituted so that test-retest reliability could be assessed. Each child was then diagnosed and treated in accordance with standard care practices. The third PCQ was administered 3 weeks after the second to determine if it would accurately reflect the parent's perception of how the child's cough had changed following treatment. Also, at the second and third encounters, parents were asked to provide their global assessment of whether their child's cough had improved, worsened, or stayed the same since the previous encounter. The parents of 120 children (70 boys and 50 girls; mean age: 6.8 yr) completed all three PCQs. Test-retest reliability was established (p < 0.001) for each of the five PCQ questions by Spearman correlation analysis (Q1: r = 0.5; Q2: r = 0.38; Q3: r = 0.42; Q4: r = 0.53; Q5: r = 0.5). Other statistical analyses confirmed the PCQ's internal consistency, discriminant validity, and convergent validity. Based on our findings, we conclude that the PCQ is a valid and reliable instrument with which to follow children with chronic cough longitudinally.
Article
Full-text available
Concerns about the safety and efficacy of over-the-counter cold medications have led to a recent US Food and Drug Administration public health advisory against their use in children <2 years of age. Our goal was to examine caregiver understanding of the age indication of over-the-counter cold medication labels and identify factors, associated with caregiver understanding. Caregivers of infant children (< or =1 year old) were recruited from clinics at 3 institutions. Questions were administered regarding the use of 4 previously common "infant" over-the-counter cold and cough medicines labeled to consult a physician if used in children <2 years of age. Literacy and numeracy skills were assessed with validated instruments. A total of 182 caregivers were recruited; 87% were the infants' mothers. Mean education level was 12.5 years, and 99% had adequate literacy skills, but only 17% had >9th-grade numeracy skills. When examining the front of the product label, 86% of the time parents thought these products were appropriate for use in children <2 years of age. More than 50% of the time, parents stated they would give these over-the-counter products to a 13-month-old child with cold symptoms. Common factors that influenced parental decisions included label saying "infant," graphics (eg, infants, teddy bears, droppers), and dosing directions. Caregivers were influenced by the dosing directions only 47% of the time. Caregivers with lower numeracy skills were more likely to provide inappropriate reasons for giving an over-the-counter medication. Misunderstanding of over-the-counter cold products is common and could result in harm if medications are given inappropriately. Label language and graphics seem to influence inappropriate interpretation of over-the-counter product age indications. Poorer parental numeracy skills may increase the misinterpretation of these products. Opportunities exist for the Food and Drug Administration and manufacturers to revise existing labels to improve parental comprehension and enhance child safety.
Article
Full-text available
The use of nonprescription cough and cold medicines is widespread, but their use has been sporadically associated with severe toxicity and death. We evaluate the role of these medications in pediatric fatalities and identified factors that contributed to the death. Fatalities that involved a child younger than 12 years and mentioned a cough and cold ingredient were obtained from 5 sources. An independent panel of 8 experts (pediatrics, pediatric critical care, pediatric toxicology, clinical toxicology, forensic toxicology, forensic pathology) used explicit definitions to assess the causal relationship between medication ingestion and death. Contributing factors were identified. Of 189 cases included, 118 were judged possibly, likely, or definitely related to a cough and cold ingredient. Of these 118 cases, 103 involved a nonprescription drug, whereas 15 cases involved a prescription medication alone. Of 103 cases associated with nonprescription drugs, the evidence indicated that 88 involved an overdosage. A dosage could not be assessed in the remaining 15 cases. Several contributing factors were identified: age younger than 2 years, use of the medication for sedation, use in a daycare setting, use of 2 medicines with the same ingredient, failure to use a measuring device, product misidentification, and use of a nonprescription product intended for adult use. All cases that occurred in a daycare setting involved a child younger than 2 years. In our sample, pediatric fatalities caused by nonprescription cough and cold medications were uncommon, involved overdose, and primarily affected children younger than 2 years. The intent of caregivers appears to be therapeutic to relieve symptoms in some cases and nontherapeutic to induce sedation or to facilitate child maltreatment in other cases.
Article
The present study was performed to clarify the possible causes of the antimicrobial activity of honey A sugar solution resembling honey in its high sugar content was made. The antimicrobial activities of both honey and this solution towards 21 types of bacteria and two types of fungi were examined. The results achieved by both were compared. The difference between them indicated the presence of antimicrobial substance(s) in honey The kinds of antimicrobial substances (inhibines) in honey are discussed. Hydrogen peroxide is not the only inhibine in honey. In fact, inhibines in honey include many other substances. Two important classes of these inhibines are the flavonoids and the phenolic acids. Flavonoids have often been extracted from honey previously. In this study two phenolic acids (caffeic acid and ferulic acid) were extracted from honey for the first time.
Article
The present study was performed to clarify the possible causes of the antimicrobial activity of honey. A sugar solution resembling honey in its high sugar content was made. The antimicrobial activities of both honey and this solution towards 21 types of bacteria and two types of fungi were examined. The results achieved by both were compared. The difference between them indicated the presence of antimicrobial substance(s) in honey. The kinds of antimicrobial substances (inhibines) in honey are discussed. Hydrogen peroxide is not the only inhibine in honey. In fact, inhibines in honey include many other substances. Two important classes of these inhibines are the flavonoids and the phenolic acids. Flavonoids have often been extracted from honey previously. In this study two phenolic acids (caffeic acid and ferulic acid) were extracted from honey for the first time.
Article
Coughing is a prevalent symptom of upper respiratory infections (URIs) that cause disturbance in the sleep of children and their parents. There is as yet no reliable treatment to control URIs and their related cough; however, drugs such as dextromethorphan (DM) and diphenhydramine (DPH) are now mainly used in the world. The aim of this study is to compare the effect of honey, DM, and DPH on the nightly cough and sleep quality of children and their parents. This was a clinical trial study in which 139 children aged 24-60 months suffering from coughing due to URIs were selected and assigned randomly to 4 groups. The first group received honey (HG), the second one DM (DMG), the third DPH (DPHG), but the fourth group or control group (CG) was assigned to a supportive treatment. After approximately a 24-hour intervention, the 4 groups were reexamined and their cough frequency, cough severity, and sleep quality in children and their parents were recorded by using the questionnaire with Likert-type questions. The mean of cough frequency score HG is 4.09 +/- 0.72 and 1.93 +/- 0.65 before and after the intervention, respectively, while these figures for the CG are 4.11 +/- 0.78 and 3.11 +/- 0.57, respectively. After the intervention, the difference of the mean score of the variables in all groups became statistically significant. The mean score of all variables in HG has stood significantly higher than those in other groups. There is also a significant relationship between the DMG and CG groups, even though there is no statistically difference between DMG and DPHG groups. The result of the study demonstrated that receiving a 2.5-mL dose of honey before sleep has a more alleviating effect on URIs-induced cough compared with DM and DPH doses.